Dyspnea Treatment Market Set to Surge to US$ 11.01 Billion By 2032, An Aging Population & …
The growing number of people suffering from respiratory disorders like chronic obstructive pulmonary disease (COPD), asthma, and heart conditions, which often cause shortness of breath (dyspnea), is a major factor driving the market's growth.
“According to SNS Insider Research, The Dyspnea Treatment Market Size was valued at US$ 6.16 billion in 2023, and is expected to reach US$ 11.01 billion by 2032, and grow at a CAGR of 6.95% over the forecast period 2024-2032.”